Yoneda Toshiyuki, Hiasa Masahiro, Nagata Yuki, Okui Tatsuo, White Fletcher
Department of Medicine, Hematology/Oncology, Indiana University School of Medicine, 980 W. Walnut Street, Indianapolis, IN 46202, USA.
Department of Anesthesia, Paul and Carole Stark Neurosciences Research Institute, Indiana University, 320 West 15th Street, Indianapolis, IN 46202, USA.
Biochim Biophys Acta. 2015 Oct;1848(10 Pt B):2677-84. doi: 10.1016/j.bbamem.2015.02.004. Epub 2015 Feb 14.
Solid and hematologic cancer colonized bone produces a number of pathologies. One of the most common complications is bone pain. Cancer-associated bone pain (CABP) is a major cause of increased morbidity and diminishes the quality of life and affects survival. Current treatments do not satisfactorily control CABP and can elicit adverse effects. Thus, new therapeutic interventions are needed to manage CABP. However, the mechanisms responsible for CABP are poorly understood. The observation that specific osteoclast inhibitors can reduce CABP in patients indicates a critical role of osteoclasts in the pathophysiology of CABP. Osteoclasts create an acidic extracellular microenvironment by secretion of protons via vacuolar proton pumps during bone resorption. In addition, bone-colonized cancer cells also release protons and lactate via plasma membrane pH regulators to avoid intracellular acidification resulting from increased aerobic glycolysis known as the Warburg effect. Since acidosis is algogenic for sensory neurons and bone is densely innervated by sensory neurons that express acid-sensing nociceptors, the acidic bone microenvironments can evoke CABP. Understanding of the mechanism by which the acidic extracellular microenvironment is created in cancer-colonized bone and the expression and function of the acid-sensing nociceptors are regulated should facilitate the development of novel approaches for management of CABP. Here, the contribution of the acidic microenvironment created in cancer-colonized bone to elicitation of CABP and potential therapeutic implications of blocking the development and recognition of acidic microenvironment will be described. This article is part of a Special Issue entitled: Membrane channels and transporters in cancers.
实体癌和血液系统癌转移至骨会引发多种病理状况。最常见的并发症之一是骨痛。癌症相关性骨痛(CABP)是发病率增加的主要原因,会降低生活质量并影响生存期。目前的治疗方法无法令人满意地控制CABP,且可能引发不良反应。因此,需要新的治疗干预措施来管理CABP。然而,CABP的发病机制尚不清楚。特定破骨细胞抑制剂可减轻患者CABP这一观察结果表明破骨细胞在CABP的病理生理学中起关键作用。破骨细胞在骨吸收过程中通过液泡质子泵分泌质子,从而营造出酸性细胞外微环境。此外,骨转移癌细胞还通过质膜pH调节剂释放质子和乳酸,以避免因有氧糖酵解增加(即瓦伯格效应)导致的细胞内酸化。由于酸中毒会刺激感觉神经元,且骨由表达酸敏伤害感受器的感觉神经元密集支配,因此酸性骨微环境可引发CABP。了解癌症转移至骨时酸性细胞外微环境的形成机制以及酸敏伤害感受器的表达和功能调控,应有助于开发管理CABP的新方法。在此,将描述癌症转移至骨时形成的酸性微环境对引发CABP的作用以及阻断酸性微环境形成和识别的潜在治疗意义。本文是名为“癌症中的膜通道与转运体”的特刊的一部分。